Skip to content
PICO Portalanswers from OpenAlex

Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine

PaperCitations, authors & open-access status

Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine is a paper indexed in PICO Portal from OpenAlex.

How many citations does Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine have?

PICO Portalcitation count

Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine has 116 citations in the OpenAlex counts PICO Portal stores.

When was Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine published?

PICO Portalyear

Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine has 2005 year in the PICO Portal index.

What is the open-access status of Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine?

PICO Portaloa status

Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine has closed oa status in the PICO Portal index.

What is the DOI of Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine?

PICO Portaldoi

The DOI for Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine is on the source record.

What is the PMID of Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine?

PICO Portalpmid

The PMID for Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine is on the source record.

What is the OpenAlex record for Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine?

PICO Portalopenalex

The OpenAlex for Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial